Nephrocare Health Services Lists at 7% Premium Over IPO Price
AI Summary1 min read
TL;DR
Nephrocare Health Services listed at a 7% premium over its IPO price, with strong demand and plans to use proceeds for debt reduction and expansion. The company showed robust financial growth, but analysts have raised valuation concerns.
Tags
Nephrocare Health ServicesIPOdialysis servicesstock marketvaluation
Nephrocare Health Services, India's largest dialysis services provider, listed at a 7% premium over its IPO price on Thursday. The Rs 871.39 crore IPO saw robust demand, with the issue subscribed 14.08 times overall. The company plans to use proceeds from the fresh issue to reduce debt and expand dialysis centers. Financially, Nephrocare has delivered strong growth, with revenue rising 34% and profit after tax jumping 91% in FY25. However, analysts have flagged valuation concerns.
